MetLife declares Q3 2026 dividend of $0.5925 per share

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

MetLife, Inc. declared a Q3 2026 dividend of $0.5925 per share, payable on September 8, 2026, to shareholders of record as of August 4, 2026.

powered bylight_fuzz_icon
45011182

*this image is generated using AI for illustrative purposes only.

MetLife, Inc. has declared a third quarter 2026 common stock dividend of $0.5925 per share, providing income to shareholders. The dividend will be paid on September 8, 2026, to shareholders listed on the company's records as of August 4, 2026.

Dividend Details

The board of directors approved the payout for the third quarter of 2026. The payment schedule is contingent upon shareholders holding the stock on the specified record date.

Event Date
Record Date August 4, 2026
Payment Date September 8, 2026

About MetLife

MetLife, Inc., through its subsidiaries and affiliates, provides insurance, annuities, employee benefits, and asset management services. Founded in 1868, the company operates in more than 40 markets globally.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might this dividend declaration influence investor sentiment toward MetLife's stock performance in the coming months?

What factors could drive MetLife to adjust its dividend policy in future quarters?

How does MetLife's dividend yield compare to its industry peers, and what might this indicate about its financial health?

like16
dislike

Barclays maintains Overweight on MetLife, raises target to $94

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Barclays analyst Alex Scott has maintained an Overweight rating on MetLife and raised the price target to $94 from $93, indicating a modestly positive outlook for the insurer's stock performance potential.

powered bylight_fuzz_icon
44902423

*this image is generated using AI for illustrative purposes only.

Barclays analyst Alex Scott has maintained an Overweight rating on MetLife and raised the price target to $94 from $93. The revised target indicates a modestly positive outlook for the insurer's stock performance potential.

Rating and Price Action

The research note affirms the positive stance on MetLife shares, listed on the NYSE under the ticker MET. The new price target represents a slight upward adjustment from the previous level of $93.

Metric Value
Rating Overweight
Previous Price Target $93
New Price Target $94
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Barclays to adjust the price target for MetLife?

How might MetLife's upcoming earnings report influence its stock performance?

What are the potential risks that could impact MetLife's ability to meet the new price target?

like15
dislike

More News on MetLife Inc